Amicar and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tambocor, and have Anaemia.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,959 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jun, 14, 2026

1,317 people reported to have side effects when taking Amicar.
Among them, 10 people (0.76%) have Hyperkalemia.

Among these 10 people:

How long have people been on Amicar when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Amicar? *

female: 60 %
male: 40 %

What is the age of people who have Hyperkalemia when taking Amicar? *

What are other drugs people take besides Amicar? *

What are other side effects people have besides Hyperkalemia? *

Blood Urea Increased: 6 people, 60.00%
Fever: 6 people, 60.00%
Blood Creatinine Increased: 6 people, 60.00%
Glomerular Filtration Rate Decreased: 5 people, 50.00%
Haematoma (collection of blood outside the blood vessels): 5 people, 50.00%
Globulins Increased: 5 people, 50.00%
Protein Total Decreased: 5 people, 50.00%
Protein Total Increased: 5 people, 50.00%
Creatinine Renal Clearance Decreased: 5 people, 50.00%
Injection Site Infection: 5 people, 50.00%

What are the existing conditions these people have? *

Anaemia (lack of blood): 2 people, 20.00%
Sedation: 1 person, 10.00%
Pain: 1 person, 10.00%
Hypoglycemia (low blood sugar): 1 person, 10.00%
High Blood Pressure: 1 person, 10.00%
Haemorrhage (bleeding): 1 person, 10.00%
Blood Potassium Decreased: 1 person, 10.00%
Blood Iron Increased: 1 person, 10.00%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amicar and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amicar:

Amicar (1,323 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Amicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,959 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,936 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.